secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001493152-25-001132
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma receives Nasdaq bid price deficiency notice; 180-day cure period until June 30, 2025
--------------------------------------------------------------------------------

- Received Nasdaq letter Dec 31, 2024 for failing to maintain minimum $1.00 bid price for 30 consecutive business days.
- Has 180 calendar days until June 30, 2025 to regain compliance by closing bid price >= $1.00 for 10 consecutive business days.
- If not compliant by June 30, may be eligible for additional 180-day period if meeting other listing standards and intending to cure via reverse stock split.
- Listing continues under symbol SHPH; company considering available options to regain compliance.
- CEO to participate in Lytham Partners fireside chat on Jan 13, 2025; plans to discuss Ropidoxuridine Phase 2 trial and Shuttle Diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225001132/0001493152-25-001132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315225001132/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer